[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"esophagojejunal-anastomotic-leak\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:esophagojejunal-anastomotic-leak":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":23,"studyType":24,"phases":4,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":5},"100615640","impact-of-endo-vac-therapy-for-esophago-jejunal-anastomotic-leak-100615640",false,"NCT07295236","Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak","Prospective Observational Study on Endo-vac Therapy for Esophago-jejunal Anastomotic Leak","ENDO-VAL","Inclusion Criteria:\n\n* patients who developed esophago-jejunal anastomotic leak less than 50% of circumference of anastomosis\n* patients who developed esophago-jejunal anastomotic leak and remained stable at the moment of diagnosis with no indications for diversion surgery\n\nExclusion Criteria:\n\n* unstable patients who developed esophago-jejunal anastomotic leak\n* patients who developed esophago-jejunal anastomotic leak more than 50% or anastomotic circumference\n* patients who rejected endoscopic vacuum therapy","ALL","18 Years","90 Years",{"count":21,"type":22},100,"ESTIMATED","5 Years","OBSERVATIONAL","The goal of this observational study is to assess the impact of endoscopic vacuum therapy in patients who underwent total gastrectomy due to gastric cancer and developed esophago-jejunal anastomotic leakage. The main outcomes to be investigated are the following:\n\nPrimary endpoint: mortality rate Secondary endpoints: morbidity rate, time from AL diagnosis to discharge, patients satisfactory rate.",[27],"Esophagojejunal Anastomotic Leak",[29,30,31,32],"gastric cancer","esophagojejunal anastomotic leak","total gastrectomy","Endoscopic vacuum therapy","RECRUITING","2025-12-21",{"date":36,"type":37},"2025-12-29","ACTUAL",{"date":39,"type":37},"2025-12-01",{"date":41,"type":22},"2035-12-01",{"name":43,"class":44},"Ukrainian Society of Clinical Oncology","OTHER"]